These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 20518016)

  • 1. Regulatory T cells in tumor immunity.
    Nishikawa H; Sakaguchi S
    Int J Cancer; 2010 Aug; 127(4):759-67. PubMed ID: 20518016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-CCR4 mAb and regulatory T cells].
    Kurose K; Ohue Y; Oka M
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in cancer immunotherapy.
    Tanaka A; Sakaguchi S
    Cell Res; 2017 Jan; 27(1):109-118. PubMed ID: 27995907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Kochin V; Nishikawa H
    Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in cancer immunotherapy.
    Nishikawa H; Sakaguchi S
    Curr Opin Immunol; 2014 Apr; 27():1-7. PubMed ID: 24413387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppression of tumor antigen-specific T cell immune responses by regulatory T cells].
    Shimazu Y; Nishikawa H
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1057-61. PubMed ID: 25248887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
    Campbell JR; McDonald BR; Mesko PB; Siemers NO; Singh PB; Selby M; Sproul TW; Korman AJ; Vlach LM; Houser J; Sambanthamoorthy S; Lu K; Hatcher SV; Lohre J; Jain R; Lan RY
    Cancer Res; 2021 Jun; 81(11):2983-2994. PubMed ID: 33757978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune responses towards regulatory cells.
    Larsen SK
    Dan Med J; 2016 Jan; 63(1):B5188. PubMed ID: 26726907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.
    Perret R; Sierro SR; Botelho NK; Corgnac S; Donda A; Romero P
    Cancer Res; 2013 Nov; 73(22):6597-608. PubMed ID: 24048821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peripheral tolerance to allergen mediated by regulatory T cells].
    Yamaguchi T; Sakaguchi S
    Nihon Rinsho; 2009 Nov; 67(11):2063-70. PubMed ID: 19899517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
    Villarreal DO; L'Huillier A; Armington S; Mottershead C; Filippova EV; Coder BD; Petit RG; Princiotta MF
    Cancer Res; 2018 Sep; 78(18):5340-5348. PubMed ID: 30026324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in immune surveillance and treatment of cancer.
    Yamaguchi T; Sakaguchi S
    Semin Cancer Biol; 2006 Apr; 16(2):115-23. PubMed ID: 16376102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
    Ohkura N; Hamaguchi M; Sakaguchi S
    Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulatory T cells: A target in anticancer immunotherapy].
    Enokida T; Nishikawa H
    Nihon Rinsho; 2017 Feb; 75(2):181-187. PubMed ID: 30562850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.